ARKG vs DFAC
ARK Genomic Revolution ETF vs Dimensional US Core Equity 2 ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
DFAC—
Dimensional US Core Equity 2 ETF
Broad US equity market with small and value tilts.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | DFAC |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Dimensional |
ARKG top holdings
Holdings data unavailable for ARKG.
DFAC top holdings
Holdings data unavailable for DFAC.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About DFAC
DFAC (Dimensional US Core Equity 2 ETF) is Broad US equity market with small and value tilts.